Salbutamol (Salamol Easi-Breathe)
Is It Right for You?
A complete guide to Salbutamol (Salamol Easi-Breathe) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Salbutamol (Salamol Easi-Breathe)?
Salbutamol, available as the Salamol Easi-Breathe inhaler (100 micrograms per actuation), is a short-acting beta-2 agonist (SABA) bronchodilator — the most widely used reliever inhaler for asthma in the UK. It provides rapid, on-demand relief of acute bronchoconstriction by relaxing the smooth muscle of the airways within minutes of inhalation.
The Salamol Easi-Breathe is a breath-actuated pressurised metered-dose inhaler (pMDI), designed to automatically discharge the dose when the patient inhales — eliminating the coordination challenge associated with standard press-and-breathe inhalers. This makes it particularly suitable for children, elderly patients, or anyone who finds coordinating a standard pMDI difficult.
Salbutamol is a prescription-only medication in the UK. A clinician must diagnose and review your respiratory condition before prescribing.
What Conditions Is Salbutamol Used For?
Salbutamol is indicated for:
rapid relief of acute bronchospasm triggered by allergens, exercise, infection, or other stimuli; the cornerstone of as-needed asthma management
taken 10–15 minutes before exercise to prevent exercise-induced wheeze and breathlessness
used as a reliever in COPD alongside maintenance bronchodilator therapy (long-acting beta-2 agonists and/or anticholinergics)
Salbutamol is a rescue bronchodilator. It relieves symptoms rapidly but does not address the underlying eosinophilic airway inflammation that drives asthma. Regular preventer therapy (inhaled corticosteroid) is the cornerstone of asthma control. Increasing reliance on salbutamol — using it more than twice a week — is a reliable indicator of poorly controlled asthma that requires clinical review and preventer therapy optimisation.
How Does Salbutamol Work?
Salbutamol is a selective beta-2 adrenergic receptor agonist. Following inhalation, it reaches the bronchial smooth muscle directly via the airway, with minimal systemic absorption at therapeutic doses:
Beta-2 receptor activation: Salbutamol binds to beta-2 adrenergic receptors expressed on airway smooth muscle cells, mast cells, and bronchial epithelium. Receptor binding activates membrane-bound adenylyl cyclase via a G-protein-coupled mechanism, generating a rise in intracellular cyclic AMP (cAMP).
Smooth muscle relaxation: Elevated cAMP activates protein kinase A (PKA), which phosphorylates myosin light-chain kinase and decreases intracellular calcium — causing relaxation of bronchial smooth muscle, bronchodilation, and a reduction in airway resistance. This process begins within 1–3 minutes of inhalation, with peak effect at approximately 15 minutes and duration of action of 4–6 hours.
Additional effects: Salbutamol also stabilises mast cell membranes (reducing histamine release), promotes mucociliary clearance, and reduces oedema of the bronchial mucosa — all contributing to relief of acute bronchospasm.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Using the Salamol Easi-Breathe correctly is essential. Open the cap to prime the inhaler. Hold it upright, breathe out gently away from the inhaler, place the mouthpiece in your mouth and seal your lips, then begin to inhale steadily — the inhaler fires automatically. Continue inhaling slowly and deeply, then hold your breath for 10 seconds.
Use a spacer where possible. Even with a breath-actuated inhaler, a spacer can improve drug delivery to the lungs in children and in patients with poor inspiratory flow. Ask your clinician or pharmacist whether a spacer is appropriate.
Shake before use. Although the Easi-Breathe is breath-actuated, check your device instructions regarding priming and shaking.
Monitor your use. If you are using your salbutamol inhaler more than twice a week (outside pre-exercise use), your asthma requires review — contact your clinician.
Keep a spare inhaler. Salbutamol is a rescue medication; always ensure you have an in-date spare available.
Side Effects of Salbutamol
Most side effects are mild and resolve on their own. Serious side effects are rare but require immediate medical attention.
- Tremor (fine tremor of the hands)
- Palpitations and tachycardia
- Headache
- Muscle cramps
- Hypokalaemia (low potassium)
- Paradoxical bronchospasm --- rare but potentially dangerous; inhalation causes immediate worsening of airway obstruction; discontinue and seek emergency care.
- Severe hypokalaemia --- high-dose salbutamol can cause clinically significant falls in serum potassium, risking cardiac arrhythmia; monitoring required in acute settings.
- Cardiac arrhythmias --- including atrial fibrillation and ventricular arrhythmias, particularly in patients with pre-existing cardiac disease or hypokalaemia.
- Lactic acidosis --- rare; associated with very high-dose nebulised salbutamol in severe asthma.
Using salbutamol more than twice a week (for symptom relief) indicates that asthma is not adequately controlled. Overreliance on reliever therapy — without adequate preventer (ICS) use — is associated with an increased risk of severe and fatal asthma attacks. Every patient using a salbutamol inhaler should have a written asthma action plan and regular preventer therapy review.
Drug Interactions
Salbutamol may interact with other medications, including non-selective beta-blockers, MAO inhibitors, tricyclic antidepressants, loop and thiazide diuretics, digoxin, and other sympathomimetics. Always inform your clinician about all medications you are taking.
directly antagonise the bronchodilatory effect of salbutamol; may precipitate severe bronchospasm in asthmatic patients; contraindicated in asthma; even cardioselective beta-blockers should be used with caution.
potentiate the cardiovascular effects of sympathomimetics; avoid concurrent use or use with extreme caution.
additive risk of hypokalaemia with high-dose salbutamol; monitor potassium in patients on both therapies.
high-dose salbutamol-induced hypokalaemia increases digoxin toxicity risk; monitor potassium and digoxin levels.
Important Warnings
Salbutamol reliever therapy is not sufficient to manage acute severe or life-threatening asthma. If symptoms are not improving after 4–10 puffs via spacer, if you are too breathless to speak in sentences, or if your lips are turning blue, call 999 immediately. Do not delay emergency care by continuing to use your inhaler.
Regular use of salbutamol more than twice weekly is a red-flag indicator of uncontrolled asthma. It must prompt urgent clinical review and optimisation of preventer therapy — not simply an increase in reliever use.
Salbutamol should be used with caution in patients with ischaemic heart disease, arrhythmias, or hypertension. At normal inhaled doses, cardiovascular effects are minimal, but high or repeated doses can cause clinically significant tachycardia.
In acute severe asthma requiring repeated or high-dose salbutamol, monitoring of serum potassium is required — particularly in patients on loop diuretics, theophylline, or corticosteroids, where hypokalaemia risk is amplified.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Salbutamol FAQs
Tremor is a direct pharmacological effect of beta-2 receptor stimulation on skeletal muscle. It is most noticeable after higher doses and generally subsides within 30–60 minutes. It is not dangerous, but if persistent tremor is troublesome, discuss with your clinician whether your dose or device needs reviewing.
Using salbutamol for symptom relief more than twice a week (outside pre-exercise prevention) indicates that your asthma is not adequately controlled by your current preventer therapy. This is a clinical red flag — not simply because of the side effect profile of salbutamol, but because it signals that your airways remain inflamed and you are at elevated risk of a serious attack. Contact your clinician.
The Salamol Easi-Breathe is a breath-actuated device — it fires the dose automatically when you inhale, removing the need to coordinate pressing the canister with breathing in. Standard pMDIs require simultaneous pressing and inhaling, which many patients do incorrectly, reducing the amount of drug reaching the lungs. The Easi-Breathe improves delivery reliability.
Yes. Two puffs of salbutamol taken 10–15 minutes before exercise provides effective protection against exercise-induced bronchoconstriction in most patients with asthma. If you regularly need pre-exercise salbutamol, discuss whether your maintenance therapy needs reviewing.
Yes — salbutamol is considered safe throughout pregnancy and is the recommended reliever inhaler for pregnant women with asthma. Uncontrolled asthma poses a much greater risk to the pregnancy than properly used salbutamol. Do not stop your inhaler without speaking to your clinician.